The FDA Is Broken
By Shannon Brownlee and Jeanne Lenzer,
Washington Monthly
| 07. 10. 2021
How the Food and Drug Administration messes up approval of new drugs including the new one, aducanumab, that supposedly helps Alzheimer’s disease patients.
Between 2010 and 2015, drug companies submitted data to the U.S. Food and Drug Administration (FDA) for three different drugs for Alzheimer’s disease, a devastating condition that afflicts six million Americans. The FDA rejected all three because the manufacturers failed to provide convincing evidence that their drugs actually improved symptoms of Alzheimer’s much less cured the disease. How times change. Last month, when biotech company Biogen came to the FDA with data on aducanumab, yet another Alzheimer’s drug, the evidence the company brought once again failed to show that the drug could slow or stop Alzheimer’s cognitive decline. This time, however, the FDA gave the drug a green light, prompting Michel Vounatsos, CEO of Biogen, to pronounce the decision “historic.”
It was historic all right, but not in the way Vounatsos probably meant it. The scientific data for aducanumab is so flimsy and contradictory, ten of 11 members of the FDA’s advisory committee of outside experts voted against approving the drug (the eleventh abstained). Even the FDA’s own statistician recommended the drug be rejected. When higher ups at...
Related Articles
By Emma McDonald Kennedy
| 11.25.2024
Gig work in childcare, nursing, and transportation; non-invasive prenatal testing; gene editing; and space expeditions can all be attributed to one mistaken, pervasive assumption: that “we can innovate our way out of the thorniest problems, including reproductive ones” (22). In Reproductive Labor and Innovation: Against the Tech Fix in an Era of Hype, feminist political theorist Jennifer Denbow demonstrates why the U.S. has put so much of its hopes, and its money, on technological “innovations”––and why that hasn’t addressed...
By Arwa Mahdawi, The Guardian | 11.19.2024
Photo "Elon Musk Presenting Tesla's Fully Autonomous Future" by Steve Jurvetson on Flickr (CC BY-NC-SA 2.0)
Is Elon Musk the dinner party guest from hell? It sure seems that way. Not only is the man desperate for people to...
By Colette Shade, The New Republic | 11.14.2024
Photo "Elon Musk" by Daniel Oberhaus on Flickr (CC BY-NC-SA 2.0)
Would Donald Trump have won reelection if not for the backing of the world’s richest man? We’ll never know. But that man, Elon Musk, gave Trump more than $130...
By Carter Sherman, The Guardian | 11.17.2024
The anti-abortion movement is ready for its comeback in 2025.
With the return of Donald Trump to the White House, complete with a Republican-dominated Congress, anti-abortion groups are unfurling ambitious lists of policies they hope to see ...